BLOODchip® is a DNA-chip which determines the main allelic variants of the following blood groups: ABO, RhD, RhCE, Kell, Kidd, Duffy, MNS, Diego, Dombrock and Colton, and 12 platelet antigens by analysing of 128 polymorphisms.
BLOODchip® development has been supported by some of the most relevant European clinicians and specialists. It resolves the main technological and clinical limitations of the serology, improving donor-recipient compatibility and the safety of blood transfusions:
To resolve serological discrepancies between different methods.
To allow antigen identification when antisera are unavailable (Colton, Dombrock, Jsa…).
To obtain a direct results in multi-transfused patients, where serological identification is difficult due to the presence of several antigens, as for examples Sickle Cell Disease or Thalassemia.
To identify antigens which exhibit a weakened expression (weak D variants, Partial Ds and Duffy (FyBw+)).
To characterize patients with autoantibodies easily, as for example those with Hemolytic Autoimmune Anemia.
 |
 |
With the collaboration of:
BLOODchip brochure